Small Molecules

With a focused Strategic Science Team and one of the world’s largest bioanalytical facilities, we continue to pioneer new method development techniques and apply novel technologies to help answer your analytical challenges.

We have the capability, experience and industry-leading expertise to provide bioanalytical support from discovery through to post-market clinical trials.

Download Fact Sheet: Bioanalysis of Small Molecules

Our flexible service includes comprehensive feasibility, method establishment, development and transfer capabilities, validation and sample analysis. Working with you to meet the shortest possible sample analysis timelines, we are totally committed to providing data of the highest quality using robust bioanalytical methods. We provide a single point of contact and regular project updates with the assurance of quality and accuracy from the very best scientific staff.

We have experience managing clinical programmes for all phases of drug development and molecule types and have particular strengths in:

Adopting new methodologies and techniques: Giving clients flexible capacity and choice.

New method development: Extensive experience with a wide range of species, matrices and drug types – from new chemical entities to chiral compounds, generic and over the counter drugs, peptides and comparator drugs.

New method validation: Testing and validation methods to OECD and FDA standards. We also have an extensive library of non-proprietary validated methods.

Rapid turnaround drug discovery analyses: We provide a rapid turnaround of non-regulated discovery samples with typical method setup and analyses of 5 days.

Sample analysis: We offer a rapid sample turnaround service capable of supporting first-in-human studies. We work to sponsor specific study plans as well as our own, and provide quick and accurate analysis, results, pharmacokinetic metrics and reporting.

Quality and management: Our quality is assured to GLP, GCP and cGMP standards. Sample information is managed by Watson™ LIMS. Projects are managed by a single point of contact client manager or study director and monitored by dedicated independent quality assurance personnel.

OECD - Organisation for Economic Cooperation and Development; FDA - Food and Drug Administration; GLP - Good Laboratory Practice; GCP - Good Clinical Practice; cGMP - Current Good Manufacturing Practice